Literature DB >> 20817019

Cryoballoon versus radiofrequency catheter ablation of paroxysmal atrial fibrillation: biomarkers of myocardial injury, recurrence rates, and pulmonary vein reconnection patterns.

Michael Kühne1, Yves Suter, David Altmann, Peter Ammann, Beat Schaer, Stefan Osswald, Christian Sticherling.   

Abstract

BACKGROUND: Cryoballoon ablation has emerged as a novel treatment strategy for patients with atrial fibrillation (AF).
OBJECTIVE: The purpose of this study was to compare pulmonary vein isolation (PVI) using cryoballoon ablation versus RF ablation with regard to myocardial injury, pulmonary vein (PV) reconnection patterns, and outcome.
METHODS: Fifty patients (age 59 ± 9 years, ejection fraction 0.59 ± 0.06, left atrial size 41 ± 5 mm) with paroxysmal AF were studied. Twenty-five patients underwent PVI using a 28-mm cryoballoon. A control group of 25 patients underwent PVI using an open-irrigation RF ablation catheter. Myocardial injury was determined by measuring troponin T (TnT). PV reconnection patterns were studied in case of repeat procedures.
RESULTS: Procedure duration was 166 ± 32 minutes in the cryoballoon group versus 197 ± 52 minutes in the RF group (P = .014), with similar ablation times (cryoballoon: 45 minutes [interquartile range 40-52.5 minutes]; RF: 47 minutes [interquartile range 44-65 minutes], P = .17). Postprocedural TnT in the RF group was 1.29 ± 0.41 μg/L versus 0.76 ± 0.55 μg/L in the cryoballoon group (P = .002). In 12 patients who underwent repeat ablation, 74% of PV reconnection sites were inferiorly located in the cryoballoon group compared to 17% in the RF group (P = .0004). With 1.2 ± 0.4 and 1.3 ± 0.6 procedures per patient, 88% of patients in the cryoballoon group and 92% in the RF group were in stable sinus rhythm after follow-up of 12 ± 3 months (P = NS).
CONCLUSION: Differences in the extent of myocardial injury and patterns of PV reconnection were observed between cryoballoon ablation and RF ablation of paroxysmal AF.
Copyright © 2010 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20817019     DOI: 10.1016/j.hrthm.2010.08.028

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  38 in total

1.  Efficacy of pulmonary vein isolation with a novel hot balloon ablation catheter.

Authors:  Rudolph F Evonich; David M Nori; David E Haines
Journal:  J Interv Card Electrophysiol       Date:  2012-01-08       Impact factor: 1.900

2.  Radiofrequency catheter ablation versus balloon cryoablation of atrial fibrillation: markers of myocardial damage, inflammation, and thrombogenesis.

Authors:  Bor Antolič; Andrej Pernat; Marta Cvijić; David Žižek; Matevž Jan; Matjaž Šinkovec
Journal:  Wien Klin Wochenschr       Date:  2016-06-06       Impact factor: 1.704

Review 3.  Comparison of catheter ablation for paroxysmal atrial fibrillation between cryoballoon and radiofrequency: a meta-analysis.

Authors:  Chao-Feng Chen; Xiao-Fei Gao; Xu Duan; Bin Chen; Xiao-Hua Liu; Yi-Zhou Xu
Journal:  J Interv Card Electrophysiol       Date:  2017-01-07       Impact factor: 1.900

4.  Touch-up and recurrence rates after voltage mapping for verification of pulmonary vein isolation following cryoablation of paroxysmal atrial fibrillation.

Authors:  Rajesh Malik; Bobby Malik; Tina D Hunter
Journal:  J Interv Card Electrophysiol       Date:  2019-04-02       Impact factor: 1.900

5.  Cryoballoon in atrial fibrillation ablation.

Authors:  M Schmidt; U Dorwarth; F Straube; M Wankerl; J Krieg; A W Leber; A Huber; E Hoffmann
Journal:  Herz       Date:  2012-03       Impact factor: 1.443

Review 6.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; Jose Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  J Interv Card Electrophysiol       Date:  2012-03       Impact factor: 1.900

7.  Immediate and medium-term outcomes of cryoballoon-based pulmonary vein isolation in patients with paroxysmal and persistent atrial fibrillation: single-centre experience.

Authors:  Kudret Aytemir; Ali Oto; Uğur Canpolat; Hamza Sunman; Hikmet Yorgun; Levent Şahiner; Ergün Barış Kaya
Journal:  J Interv Card Electrophysiol       Date:  2013-10-11       Impact factor: 1.900

8.  Phrenic nerve palsy during ablation of atrial fibrillation using a 28-mm cryoballoon catheter: predictors and prevention.

Authors:  Michael Kühne; Sven Knecht; David Altmann; Nadine Kawel; Peter Ammann; Beat Schaer; Stefan Osswald; Christian Sticherling
Journal:  J Interv Card Electrophysiol       Date:  2012-10-23       Impact factor: 1.900

9.  Direct pressure monitoring accurately predicts pulmonary vein occlusion during cryoballoon ablation.

Authors:  Ioanna Kosmidou; Shannnon Wooden; Brian Jones; Thomas Deering; Andrew Wickliffe; Dan Dan
Journal:  J Vis Exp       Date:  2013-02-26       Impact factor: 1.355

10.  Early release of high-sensitive cardiac troponin during complex catheter ablation for ventricular tachycardia and atrial fibrillation.

Authors:  Tobias Reichlin; Stephen J Lockwood; Michael J Conrad; Eyal Nof; Gregory F Michaud; Roy M John; Laurence M Epstein; William G Stevenson; Petr Jarolim
Journal:  J Interv Card Electrophysiol       Date:  2016-03-12       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.